Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB.
Cell Biosci. 2023 Jun 7;13(1):102. doi: 10.1186/s13578-023-01038-y.
Cell Biosci. 2023.
PMID: 37287005
Free PMC article.
L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells.
Heo Y, Ko E, Park S, Park SO, Ahn BC, Yum JS, Chun E.
Heo Y, et al.
Cancers (Basel). 2023 Aug 4;15(15):3978. doi: 10.3390/cancers15153978.
Cancers (Basel). 2023.
PMID: 37568794
Free PMC article.
Item in Clipboard
Cite
Cite